Champions Translational Discovery Network
Partner with Champions Oncology to advance translational cancer research through clinically relevant patient-derived tumor models.
Advancing Translational Oncology Research Together
Champions Oncology collaborates with leading cancer centers and academic investigators to develop clinically annotated patient-derived tumor models that support translational oncology research and therapeutic discovery.
Investigators with access to clinically relevant tumor samples are invited to submit collaboration inquiries through the Champions Translational Discovery Network.
Advances in cancer treatment depend on access to tumor models that accurately reflect real patient biology.
Through the Champions Translational Discovery Network, investigators collaborated with Champions Oncology to develop patient-derived tumor models from clinically relevant tumor samples. These models support translational research, biomarker discovery, and the development of new cancer therapies.
Our goal is simple: enable collaborations that accelerate the translation of clinical observations into scientific discovery.
Why Participate in the Network
Contribute to Cancer Research Progress
Samples contributed through the network support the development of patient-derived tumor models used in translational oncology research worldwide.
Collaborative Research
Champions Oncology works closely with investigators to co-develop patient-derived tumor models from cohorts of mutual interest
Publications
Research collaborations with Champions provide opportunities to publish in high-impact journals.
Join a Growing Research Network
Research collaborations with Champions provide opportunities to publish in high-impact journals.
What Types of Samples Are We Seeking
Champions Oncology is particularly interested in tumor samples that provide insight into clinically relevant disease biology.
-
Tumors resistant to targeted therapies
-
Late-stage, metastatic or heavily treated disease
-
Samples with detailed treatment history
-
Rare tumor subtypes or clinically unique cases
What Types of Samples Are We Seeking
Champions Oncology is particularly interested in tumor samples that provide insight into clinically relevant disease biology.
-
Tumors resistant to targeted therapies
-
Late-stage, metastatic or heavily treated disease
-
Samples with detailed treatment history
-
Rare tumor subtypes or clinically unique cases
Ethical and Regulatory Compliance
-
All human biospecimens used by Champions Oncology are collected under informed patient consent specifically tailored towards the intended use.
-
Our team works closely with clinical collaborators to ensure appropriate ethical oversight and regulatory compliance throughout the model development process.
-
This framework allows investigators and research partners to collaborate with confidence that samples meet appropriate ethical and regulatory standards.
Investigators and institutions with access to relevant tumor samples are invited to submit information through the form above.
Submissions are reviewed by the Champions Oncology scientific team to determine potential collaboration opportunities.
If your institution is interested in contributing to the development of clinically relevant patient-derived tumor models, we welcome the opportunity to explore collaboration.